Addus HomeCare Corp (ADUS) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.23%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.23% | Share-based compensation / revenue. Period ending 2026-06-30. $18.22M ÷ $1.48B × 100 ≈ 1.23% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.48B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 18.22M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 148.23M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.48B | $18.22M | $148.23M | (m) | (m) | 1.23% | (m) | (m) |
| 2026-03-31 | (m) | $1.45B | $18.25M | $142.17M | (m) | (m) | 1.26% | (m) | (m) |
| 2025-12-31 | (m) | $1.42B | $16.42M | $138.62M | (m) | (m) | 1.15% | (m) | (m) |
| 2025-09-30 | (m) | $1.35B | $14.73M | $123.25M | (m) | (m) | 1.09% | (m) | (m) |
| 2025-06-30 | (m) | $1.27B | $13.28M | $116.27M | (m) | (m) | 1.04% | (m) | (m) |
| 2025-03-31 | (m) | $1.21B | $11.72M | $109.56M | (m) | (m) | 0.97% | (m) | (m) |
| 2024-12-31 | (m) | $1.15B | $11.16M | $102.69M | (m) | (m) | 0.97% | (m) | (m) |
| 2024-09-30 | (m) | $1.13B | $10.79M | $103.75M | $8.56M | (m) | 0.95% | 12.12× | Reported |
| 2024-06-30 | (m) | $1.11B | $10.53M | $100.64M | $11.19M | (m) | 0.94% | 9.00× | Reported |
| 2024-03-31 | (m) | $1.09B | $10.29M | $95.99M | $11.40M | (m) | 0.95% | 8.42× | Reported |
| 2023-12-31 | (m) | $1.06B | $10.32M | $90.96M | $11.11M | (m) | 0.97% | 8.19× | Reported |
| 2023-09-30 | (m) | $1.03B | $10.51M | $83.80M | $10.62M | (m) | 1.02% | 7.89× | Reported |
| 2023-06-30 | (m) | $999.13M | $10.72M | $78.48M | $9.89M | (m) | 1.07% | 7.93× | Reported |
| 2023-03-31 | (m) | $976.09M | $10.79M | $73.83M | $9.55M | (m) | 1.11% | 7.73× | Reported |
| 2022-12-31 | (m) | $951.12M | $10.63M | $68.74M | $8.91M | (m) | 1.12% | 7.72× | Reported |
| 2022-09-30 | (m) | $928.71M | $10.27M | $67.28M | $7.99M | (m) | 1.11% | 8.42× | Reported |
| 2022-06-30 | (m) | $904.88M | $9.84M | $67.13M | $7.13M | (m) | 1.09% | 9.41× | Reported |
| 2022-03-31 | (m) | $885.83M | $9.68M | $67.28M | $6.41M | (m) | 1.09% | 10.50× | Reported |
| 2021-12-31 | (m) | $864.50M | $9.43M | $65.94M | $5.81M | (m) | 1.09% | 11.36× | Reported |
| 2021-09-30 | (m) | $835.85M | $9.12M | $58.29M | $4.97M | (m) | 1.09% | 11.72× | Reported |
| 2021-06-30 | (m) | $813.18M | $8.24M | $53.46M | $4.04M | (m) | 1.01% | 13.24× | Reported |
| 2021-03-31 | (m) | $779.86M | $6.84M | $46.02M | $3.50M | (m) | 0.88% | 13.16× | Reported |
| 2020-12-31 | (m) | $764.77M | $6.00M | $44.51M | $3.19M | (m) | 0.79% | 13.96× | Reported |
| 2020-09-30 | (m) | $761.15M | $5.57M | $47.32M | $3.25M | (m) | 0.73% | 14.56× | Reported |
| 2020-06-30 | (m) | $736.16M | $5.58M | $42.13M | $3.44M | (m) | 0.76% | 12.26× | Reported |
| 2020-03-31 | (m) | $700.50M | $5.94M | $39.92M | $3.40M | (m) | 0.85% | 11.76× | Reported |
| 2019-12-31 | (m) | $648.79M | $5.77M | $34.75M | $3.10M | (m) | 0.89% | 11.19× | Reported |
| 2019-09-30 | (m) | $598.42M | $5.33M | $28.05M | $3.34M | (m) | 0.89% | 8.39× | Reported |
| 2019-06-30 | (m) | $566.33M | $4.97M | $26.75M | $4.02M | (m) | 0.88% | 6.65× | Reported |
| 2019-03-31 | (m) | $547.90M | $4.48M | $25.95M | $4.72M | (m) | 0.82% | 5.49× | Reported |
| 2018-12-31 | (m) | $518.12M | $4.11M | $24.30M | $5.02M | (m) | 0.79% | 4.84× | Reported |
| 2018-12-30 | (m) | $516.65M | (m) | $22.83M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | $3.69M | $24.91M | $4.68M | (m) | (m) | 5.32× | Reported |
| 2018-06-30 | (m) | (m) | $3.32M | $24.81M | $4.01M | (m) | (m) | 6.19× | Reported |
| 2018-03-31 | (m) | (m) | $2.98M | $23.84M | $4.73M | (m) | (m) | 5.04× | Reported |
| 2017-12-31 | (m) | (m) | $2.55M | $26.24M | $4.47M | (m) | (m) | 5.87× | Reported |
| 2017-09-30 | (m) | (m) | $1.63M | $26.38M | $4.20M | (m) | (m) | 6.28× | Reported |
| 2017-06-30 | (m) | (m) | $1.34M | $23.07M | $3.98M | (m) | (m) | 5.80× | Reported |
| 2017-03-31 | (m) | (m) | $1.16M | $21.54M | $2.56M | (m) | (m) | 8.43× | Reported |
| 2016-12-31 | (m) | (m) | $1.07M | $15.23M | $2.33M | (m) | (m) | 6.53× | Reported |
| 2016-09-30 | (m) | (m) | $1.67M | $10.56M | $2.02M | (m) | (m) | 5.23× | Reported |
| 2016-06-30 | (m) | (m) | $1.64M | $12.35M | $1.55M | (m) | (m) | 7.99× | Reported |
| 2016-03-31 | (m) | (m) | $1.57M | $13.05M | $1.03M | (m) | (m) | 12.61× | Reported |
| 2015-12-31 | (m) | (m) | $1.57M | $16.02M | $786.00K | (m) | (m) | 20.39× | Reported |
| 2015-09-30 | (m) | (m) | $1.43M | $18.25M | $725.00K | (m) | (m) | 25.18× | Reported |
| 2015-06-30 | (m) | (m) | $1.25M | $18.93M | $738.00K | (m) | (m) | 25.65× | Reported |
| 2015-03-31 | (m) | (m) | $1.04M | $17.93M | $719.00K | (m) | (m) | 24.93× | Reported |
| 2014-12-31 | (m) | (m) | $827.00K | $18.07M | $698.00K | (m) | (m) | 25.89× | Reported |
| 2014-09-30 | (m) | (m) | $712.00K | $16.30M | $665.00K | (m) | (m) | 24.52× | Reported |
| 2014-06-30 | (m) | (m) | $629.00K | $15.61M | $636.00K | (m) | (m) | 24.54× | Reported |
| 2014-03-31 | (m) | (m) | $533.00K | $15.49M | $622.00K | (m) | (m) | 24.90× | Reported |
| 2013-12-31 | (m) | (m) | $515.00K | $15.46M | $674.00K | (m) | (m) | 22.94× | Reported |
| 2013-09-30 | (m) | (m) | $427.00K | $17.25M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $418.00K | $16.85M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $379.00K | $16.09M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $341.00K | $15.66M | $1.72M | (m) | (m) | 9.09× | Reported |
| 2012-09-30 | (m) | (m) | $369.00K | $11.23M | $1.96M | (m) | (m) | 5.73× | Reported |
| 2012-06-30 | (m) | (m) | $326.00K | $-4.83M | $2.10M | (m) | (m) | -2.30× | Reported |
| 2012-03-31 | (m) | (m) | $350.00K | $-4.74M | $2.34M | (m) | (m) | -2.02× | Reported |
| 2011-12-31 | (m) | (m) | $331.00K | $-4.21M | $2.52M | (m) | (m) | -1.67× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $255.00K | $11.99M | $3.16M | (m) | (m) | 3.80× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $297.00K | $11.78M | $6.77M | (m) | (m) | 1.74× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |